Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Bosentan
Status:
Completed
Trial end date:
2018-05-14
Target enrollment:
Participant gender:
Summary
the purpose of this study is:
- To assess the effect of BIA 5 1058 400 mg on the PK of bosentan.
- To assess the effect of bosentan on the PK of BIA 5 1058